News
Silver Athena Swan success for the School of Cellular and Molecular Medicine
21 April 2023
The School of Cellular and Molecular Medicine has been successful in their application for an Athena Swan Silver Award in April 2023.
- Professor Sir Anthony Epstein CBE FRS, 1921-2024 22 February 2024 Professor Sir Anthony Epstein has passed away aged 102. Dr Darryl Hill, Head of the School of Cellular and Molecular Medicine, offers a remembrance.
- University of Bristol stem cell spinout secures £7.6m seed funding 18 January 2024 CellVoyant, an AI-first biotechnology spin-out from the University of Bristol accelerating the development of new stem cell therapies, has announced a £7.6 million seed round.
- Henrietta Lacks Studentship 4 January 2024 The School of Cellular and Molecular Medicine was delighted to host two undergraduate students in November and December 2023 as part of the Henrietta Lacks Studentship programme. The programme is part of the University of Bristol’s Henrietta Lacks statue project and was supported by a philanthropic donation. It aims to address the lack of representation of the Black community at postgraduate level by supporting undergraduate students of Black heritage to gain paid experience in labs as they consider pursuing a career in research.
- Wellcome Trust Awards £3.1 Million to Bristol Researcher for Stem Cell Biology Research 4 January 2024 Dr. Bethan Lloyd-Lewis, a Vice-Chancellor’s Research Fellow at the School of Cellular and Molecular Medicine (CMM), has been awarded a £3.1 million fellowship from the Wellcome Trust to lead research into the regulatory mechanisms influencing stem cell fate decisions during organ development and cancer.
- Sir Paul Nurse OM CH FRS presents CMM Sir Anthony Epstein Lecture 2023 18 December 2023 The School of Cellular and Molecular Medicine welcomed Sir Paul Nurse OM CH FRS for the Annual Sir Anthony Epstein Lecture.
- Feeding dogs raw meat increases the risk of antibiotic-resistant E. coli 21 November 2023 Feeding dogs raw (uncooked) meat increases their risk of excreting E. coli that cannot be killed by a widely used antibiotic - ciprofloxacin - researchers at the University of Bristol have found from a study of 600 healthy pet dogs.
- Pioneering new childhood cancer research projects announced by The Little Princess Trust 28 September 2023 The Little Princess Trust has announced funding of three ground breaking childhood cancer research projects including a new University of Bristol-led study that will investigate how protein production is changed in childhood cancer cells.
- Spotlight Series: Dr Parthive Patel 18 September 2023 As part of our CMM Spotlight Series, PhD students' Dora Bonini and Michaela Gregorova interview Dr Parthive Patel - a Sir Henry Dale Research Fellow in CMM.
- Screening has a critical effect on reducing bowel cancer incidence in England 9 August 2023 Screening has reduced the incidence of bowel cancer finds a new study jointly led by researchers from the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust.
- Long Covid not caused by COVID-19 immune inflammatory response, new research finds 4 August 2023 Long Covid, which affects nearly two million people in the UK (1), is not caused by an immune inflammatory reaction to COVID-19, University of Bristol-led research finds. Emerging data demonstrates that immune activation may persist for months after COVID-19.